Shrestha, Rupendra. 2020. “Induced Pluripotent Stem Cells Are Japanese Brand Sources for Therapeutic Cells to Pretrial Clinical Research”. Progress in Stem Cell 7 (1), 296-303. https://doi.org/https://doi.org/10.15419/psc.v7i1.409.